Advertisement
Screener

Palvella Therapeutics, Inc. (PVLA) Net Margin

Palvella Therapeutics, Inc. (PVLA) Net Margin

  • 2024-03-31: Net Margin -42266.67%.
  • 2023-12-31: Net Margin 3695.03%.
  • 2023-09-30: Net Margin -69.06%.
  • 2023-06-30: Net Margin 19.79%.

Complete source-backed net margin history.

Available history
2013-12-31 to 2024-03-31
Data captured

Historical Net Margin

DateNet Margin
2024-03-31-42266.67%
2023-12-313695.03%
2023-09-30-69.06%
2023-06-3019.79%
2023-03-31-655.87%
2022-12-31-141.92%
2022-09-30-190.45%
2022-06-30-298.10%
2022-03-31-45.63%
2021-12-31-122.98%
2021-09-30-594.18%
2021-06-30-610.16%
2021-03-31-28.06%
2020-12-31-948.62%
2020-09-30-554.03%
2020-06-30-45.29%
2020-03-31-40.48%
2019-12-31-4.62%
2019-09-30-17.88%
2019-06-30-238.31%
2019-03-31-137.35%
2018-12-31-248.18%
2018-09-30-78.15%
2018-06-30-1.81%
2018-03-31-253.02%
2017-12-3141.27%
2017-09-30-179.76%
2017-06-30-544.25%
2017-03-31-595.23%
2016-12-31-240.55%
2016-09-30-789.32%
2016-06-30-548.37%
2016-03-31-333.78%
2015-12-31-135.63%
2015-09-30-946.01%
2015-06-30-2202.89%
2015-03-31-1702.38%
2014-12-31-127.21%
2014-09-30-10799.78%
2014-06-30-412.71%
2014-03-31-56.81%

Annual Net Margin

DateNet Margin
2023-12-3148.28%
2022-12-31-130.66%
2021-12-31-163.70%
2020-12-31-155.70%
2019-12-31-58.35%
2018-12-31-98.19%
2017-12-31-69.82%
2016-12-31-391.00%
2015-12-31-479.50%
2014-12-31-183.59%
2013-12-310.53%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Generate Biomedicines, Inc. (GENB)United States$2.052B
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12